Halbert Hargrove Global Advisors, LLC Eli Lilly & CO Transaction History

Halbert Hargrove Global Advisors, LLC

  • $1.53 Billion
  • Q1 2024

A detailed history of Halbert Hargrove Global Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Halbert Hargrove Global Advisors, LLC holds 2,193 shares of LLY stock, worth $1.99 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,193
Previous 2,182 0.5%
Holding current value
$1.99 Million
Previous $1.27 Million 34.23%
% of portfolio
0.11%
Previous 0.09%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024
BUY
$592.2 - $792.28 $6,514 - $8,715
11 Added 0.5%
2,193 $1.71 Million
Q4 2023

Jan 23, 2024
BUY
$525.19 - $619.13 $4,201 - $4,953
8 Added 0.37%
2,182 $1.27 Million
Q3 2023

Oct 13, 2023
SELL
$434.7 - $599.3 $9,563 - $13,184
-22 Reduced 1.0%
2,174 $1.17 Million
Q2 2023

Aug 14, 2023
SELL
$350.74 - $468.98 $434,216 - $580,597
-1,238 Reduced 36.05%
2,196 $1.03 Million
Q1 2023

Apr 25, 2023
SELL
$310.63 - $364.82 $174,574 - $205,028
-562 Reduced 14.06%
3,434 $1.18 Million
Q4 2022

Jan 25, 2023
BUY
$321.55 - $374.67 $28,939 - $33,720
90 Added 2.3%
3,996 $0
Q3 2022

Oct 24, 2022
BUY
$296.48 - $337.87 $3,854 - $4,392
13 Added 0.33%
3,906 $1.26 Million
Q2 2022

Aug 05, 2022
BUY
$278.73 - $327.27 $631,602 - $741,593
2,266 Added 139.27%
3,893 $1.26 Million
Q1 2022

May 13, 2022
BUY
$234.69 - $291.66 $7,744 - $9,624
33 Added 2.07%
1,627 $466,000
Q4 2021

Feb 14, 2022
BUY
$224.85 - $279.04 $1,124 - $1,395
5 Added 0.31%
1,594 $440,000
Q3 2021

Oct 29, 2021
SELL
$221.6 - $272.71 $3,545 - $4,363
-16 Reduced 1.0%
1,589 $367,000
Q1 2021

May 06, 2021
SELL
$164.32 - $212.72 $14,131 - $18,293
-86 Reduced 5.09%
1,605 $300,000
Q4 2020

Feb 04, 2021
SELL
$130.46 - $172.63 $2,217 - $2,934
-17 Reduced 1.0%
1,691 $285,000
Q3 2020

Nov 10, 2020
SELL
$146.22 - $169.13 $731 - $845
-5 Reduced 0.29%
1,708 $253,000
Q2 2020

Aug 10, 2020
BUY
$136.42 - $164.18 $12,550 - $15,104
92 Added 5.68%
1,713 $281,000
Q1 2020

May 01, 2020
SELL
$119.05 - $147.35 $2,619 - $3,241
-22 Reduced 1.34%
1,621 $225,000
Q4 2019

Feb 12, 2020
BUY
$106.92 - $132.43 $175,669 - $217,582
1,643 New
1,643 $216,000

Others Institutions Holding LLY

# of Institutions
3,719
Shares Held
738M
Call Options Held
7.09M
Put Options Held
7.24M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Halbert Hargrove Global Advisors, LLC Portfolio

Follow Halbert Hargrove Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email